<code id='ADBAF1F62B'></code><style id='ADBAF1F62B'></style>
    • <acronym id='ADBAF1F62B'></acronym>
      <center id='ADBAF1F62B'><center id='ADBAF1F62B'><tfoot id='ADBAF1F62B'></tfoot></center><abbr id='ADBAF1F62B'><dir id='ADBAF1F62B'><tfoot id='ADBAF1F62B'></tfoot><noframes id='ADBAF1F62B'>

    • <optgroup id='ADBAF1F62B'><strike id='ADBAF1F62B'><sup id='ADBAF1F62B'></sup></strike><code id='ADBAF1F62B'></code></optgroup>
        1. <b id='ADBAF1F62B'><label id='ADBAF1F62B'><select id='ADBAF1F62B'><dt id='ADBAF1F62B'><span id='ADBAF1F62B'></span></dt></select></label></b><u id='ADBAF1F62B'></u>
          <i id='ADBAF1F62B'><strike id='ADBAF1F62B'><tt id='ADBAF1F62B'><pre id='ADBAF1F62B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:22275
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Diagnostic tests are hitting their mathematical limits
          Diagnostic tests are hitting their mathematical limits

          Worriedaboutyourhealth?Youcannowavailyourselfofnoninvasivediagnosticsthatclaimtoscreenforrarebirthde

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

          DarronCummings/APScientistsattheFoodandDrugAdministrationhavetwobigquestionsaboutEliLilly’sexperimen